Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy Regimens
91%
Non Small Cell Lung Cancer
75%
Malignant Neoplasm
59%
Cisplatin
49%
Neoplasm
37%
Gemcitabine
36%
Liver Cell Carcinoma
36%
Diseases
36%
Integrin
30%
Epidermal Growth Factor Receptor
30%
Vinorelbine
29%
Fluorouracil
29%
Folinic Acid
26%
Breast Cancer
25%
Etoposide
24%
Lung Adenocarcinoma
22%
Colorectal Carcinoma
22%
Patient History of Chemotherapy
20%
Ifosfamide
19%
Pharmacokinetics
19%
Small Cell Lung Cancer
19%
Lung Cancer
19%
Docetaxel
18%
Paclitaxel
18%
Anticarcinogen
18%
Cytotoxicity
17%
Phase II Trials
16%
Neutropenia
15%
Gefitinib
14%
Carboplatin
14%
Resveratrol
14%
Cancer Growth
14%
Mouth Cancer
13%
Pancreas Cancer
13%
Clinical Trial
12%
Doxorubicin
12%
Chromosome Aberration
12%
Platinum
11%
Abdominal Cancer
11%
Epirubicin
11%
Programmed Death 1 Ligand 1
11%
DNA Topoisomerase
11%
Thyroid Hormone
11%
Bone Marrow Suppression
10%
Mitogen Activated Protein Kinase 3
10%
Estrogen Receptor
10%
Nasopharynx Carcinoma
10%
Oxaliplatin
10%
Androgen
9%
Progression Free Survival
9%
Medicine and Dentistry
Chemotherapy
51%
Diseases
46%
Neoplasm
40%
Cell Line
31%
Cancer Cell
30%
Lymphocyte
28%
Epidermal Growth Factor Receptor
24%
Abdominal Cancer
23%
Chromosome
22%
Chromosome Aberration
22%
Hepatocellular Carcinoma
21%
Integrin
20%
Chronic Myelogenous Leukemia
20%
Fluorouracil
20%
Leukemia
20%
Combination Chemotherapy
19%
Small Cell Lung Cancer
18%
Cisplatin
18%
Tumor
18%
Lung Adenocarcinoma
17%
Folinic Acid
17%
Non Small Cell Lung Cancer
17%
Malignant Neoplasm
17%
Aneuploidy
15%
Gefitinib
14%
Adenocarcinoma
14%
Cancer
14%
Hyperthermia
13%
Colorectal Carcinoma
13%
Arm
13%
Karyotype
13%
Radiation Therapy
13%
Lung Cancer
12%
Pancreas Cancer
12%
Tumor Cell
11%
Etoposide
11%
Programmed Death 1 Ligand 1
11%
Epidermal Growth Factor Receptor Kinase Inhibitor
11%
Breast Cancer
11%
Infusion
10%
Lung
10%
Myeloproliferative Disorder
10%
Ovarian Cancer
9%
T Cell
9%
Gemcitabine
9%
Patient History of Chemotherapy
9%
Doxorubicin
9%
Overall Survival
9%
Thyroid Hormone
9%
Primary Tumor
9%
Biochemistry, Genetics and Molecular Biology
Cytogenetics
100%
Chromosome
77%
Cancer Cell
71%
Chromosomal Abnormalities
33%
Integrin
28%
Karyotype
25%
Philadelphia Chromosome
23%
Gene Expression
22%
Resveratrol
19%
Lymphocyte
18%
Chromosome Marker
17%
Thyroid Hormone
15%
Chromosome Analysis
15%
DNA Gyrase
13%
Colon
13%
Chromosome Number
12%
Topoisomerase
11%
DNA Topoisomerase
11%
Programmed Cell Death
11%
Signal Transduction
11%
Epidermal Growth Factor Receptor
11%
Oncogene
11%
Cell Growth
11%
Carcinogenesis
11%
Cell Proliferation
11%
Ewing Sarcoma
10%
Estrogen Receptor
10%
Aneuploidy
10%
Stem Cell
10%
Gene Amplification
10%
Morphology
10%
Chromosomal Translocation
10%
Sister Chromatid Exchange
10%
Chromosome Abnormality
10%
P53
10%
Metaphase
9%
Genomics
9%
RNA
8%
Catenin
8%
Marker Chromosome
8%
Genetics
8%
Cisplatin
8%
Messenger RNA
7%
Normal Human
7%
T Cell
7%
Leporidae
7%
Phytohaemagglutinin
7%
Myeloid
7%
Leukocyte
6%
Chromosomal Aberration
6%
